Actively Recruiting

Age: 18Years +
All Genders
ID06887387

Application of Wearable Devices for Remote QT Interval Monitoring and Symptom Investigation for Patients With Long QT Syndrome

Led by Queen Mary University of London · Updated on 2026-05-19

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether wearable devices can effectively monitor patients with Long QT Syndrome by measuring their heart's QT interval remotely. This observational study aims to compare wearable device ECG measurements with the current standard tests like 12-lead ECGs and ambulatory monitors to assess accuracy and variability over a 3-month period. Participants will use wearable devices, such as Fitbit, to record ECGs weekly for up to 3 months. The study will analyze the data to understand QT interval changes, symptom causes, and develop automated analysis tools for future use with machine learning techniques. This approach does not affect participants' usual clinical care. During the study, participants will have their ECG data collected remotely via wearable devices and smartphones. Researchers will evaluate the accuracy of these measurements and symptom relationships while monitoring heart rhythm variability. The study lasts 3 months from enrollment, with no changes to routine care or additional invasive procedures required.

CONDITIONS

Brief Title

Wearable Devices for Patient Monitoring in Long QT Syndrome

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of Long QT Syndrome
  • Aged 18 years or over
  • Phone with iOS version 15 or Android OS 9.0 or higher
  • Able and willing to provide informed consent
Not Eligible

You will not qualify if you...

  • Unwilling or unable to give consent
  • Ventricular pacing at recruitment
  • Bundle branch block or pre-excitation at baseline

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - 3 months

Participants who undergo routine care are observed using wearable devices to remotely monitor QT intervals and symptoms.

Weekly visits for data collection remotely

Trial Site Locations

Total: 1 location

1

Barts and London Hospital NHS Trust

London, United Kingdom

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Building of a Diagnostic/Prognostic Database by High-through...

Long QT Syndrome

Actively Recruiting

2 locations

Longterm Outcome and Predictors for Recurrence After Medical...

Arrhythmias, Cardiac

Actively Recruiting

1 location

Comparing Direct and Indirect Methods for Cascade Screening ...

Long QT Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here